MRI-Assisted Radiosurgery (MARS) HDR prostate brachytherapy is a reality @MDAndersonNews with Orion MRI markers and ioMRI suite. Many thanks to @PeteRossiMD for hosting and sharing his knowledge and expertise here in Houston.
Steven J. Frank, MD
@SJFrankMD
Executive Director, Particle Therapy Institute @MDAndersonNews; specializes in #headandneckcancer #MARS #prostatecancer #protontherapy. Tweets are my own.
1.4K Following 2.4K Followers 448 Posts
Latest posts 5
A sincere appreciation and acknowledgment to the 440 patients, investigators, and institutions who participated on this Phase III randomized trial highlighting the ability of proton therapy (IMPT) to de-intensify treatment and improve survival @MDAndersonNews
Results from a study led by @SJFrankMD found a survival benefit for patients with oropharyngeal cancers treated with proton therapy than the patients receiving traditional radiation therapy.View quoted post on X
More on the findings, published today in @TheLancet: spr.ly/6014CDJfp #EndCancer
MRI-Assisted Radiosurgery - MARS LDR Brachytherapy - Optimizing quality assurance and increasing dose to dominant intraprostatic lesions while avoiding the external urethral sphincter (EUS) @MDAndersonNews @ACKoongMDPhD
Congrats to @MDAndersonNews brachytherapy team for completing the first prostate case in our new suite with both MRI and CT capabilities. @SJFrankMD #radonc #endcancerView quoted post on X
Instead of removing the eye, proton therapy provides an orbit sparing approach for cure, clear vision, and good cosmesis (3Cs) for periorbital tumors @MDAndersonNews
The preciseness of proton therapy can limit the tumor-damaging energy to target areas and protect healthy structures.View quoted post on X
This helps limit side effects for patients like Michael Morin. Read his story: bit.ly/3Ar4jiH @EhabHannaMD @SJFrankMD #EyeCancer #EndCancer
Congratulations to @MDAndersonNews and all the participating institutions for developing Level 1 evidence for proton therapy for oropharyngeal tumors @ACKoongMDPhD @PTCOG @ASTRO_org @PTCOGNA @naptprotons
“The results of this multi-center Phase III randomized trial provide evidence for intensity modulated proton therapy as a new standard-of-care treatment approach for the management of head and neck tumors,” says our @SJFrankMD of research presented at #ASCO24. (Abstract 6006) bit.ly/45gQIpK @ASCO #EndCancerView quoted post on X